
Given the evolving landscape of therapeutic options for RAIR-DTC, it is essential to highlight the importance of timely evaluating patients with advanced thyroid cancer.
Given the evolving landscape of therapeutic options for RAIR-DTC, it is essential to highlight the importance of timely evaluating patients with advanced thyroid cancer.
From Clinical Thyroidology® for the Public: Surgery to remove all, or part, of the thyroid…
Latest Impact Factor: Latest Impact Factor: 6.568 The Official Journal of: American Thyroid Association® FREE…
Read and share featured articles from the July issue with free access through August 3,…
From Clinical Thyroidology® for the Public: If surgery is needed in patients with hyperthyroidism, it…
Register today to attend the ATA Annual Meeting on October 19-23, 2022 in Montreal, Canada. Register by July 1, 2022 and save!
Read and share featured articles from the June issue with free access through July 1,…
From Clinical Thyroidology® for the Public: The number of people diagnosed with thyroid cancer every…
Thyroid cancers (TC) are driven by a handful of genetic alterations. Papillary TC primarily harbors mutations involving BRAF, RAS or RET genes.
Read and share featured articles from the May issue with free access through June 12,…